Study of Serum Tumor Markers of HBV Associated HCC

Not yet recruitingOBSERVATIONAL

Enrollment

164

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

January 31, 2025

Study Completion Date

December 31, 2025

Conditions

HCC

Interventions

DIAGNOSTIC_TEST

tumor tissue and blood tests

In this study, we need to collect an extra tube of blood for routine testing and the tissue after completion of pathological examination.

All Listed Sponsors

lead

Qianfoshan Hospital

OTHER

NCT05825196 - Study of Serum Tumor Markers of HBV Associated HCC | Biotech Hunter | Biotech Hunter